Delivery Order SPE2DB22D3011-SPE2DB24FQ2ER
Award Date
6/25/24
Potential Completion Date
7/17/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,251.00 contract covers the delivery of INBRIJA 42 MG INHALATION CAP 60S, a specialized pharmaceutical product. The contract has a completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,876.50, is a Firm Fixed Price Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a period of performance through November 5, 2024. The contract does not have a set-aside designation. As a prime contractor, Amerisourcebergen has been awarded multiple...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of INBRIJA 42 MG INHALATION CAP 60S medication. The $1,294.24 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), which is a component of the Department of Defense that specializes in supply chain management and the procurement of medical supplies. The contract has an ultimate completion date of January 13, 2025 and is not designated as...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a potential value of $1,876.50. This contract has a completion date of March 13, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as a prime contractor to DLA Troop Support Medical, providing a range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 firm fixed-price delivery order is for the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, to the U.S. government. The contract, valued at $1,251.00, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order with a firm fixed price, and the agency responsible is the Medical Supply Chain, a defense agency. Amerisourcebergen Drug Corp holds a significant Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563755756 INBRIJA 42 MG INHALATION CAP 60S. The contract has a potential value of $1,251.00 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The firm fixed price delivery order, valued at $1,251.00, is for the supply of the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. This award does not have a set-aside designation. The delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of INBRIJA 42 MG Inhalation Capsules. The $1,876.50 firm-fixed-price delivery order is not designated as a set-aside contract. The award falls under a broader Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for the supply of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,876.50 firm-fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAPSULES. This contract has an ultimate completion date of August 8, 2024 and is not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...